| 2021 | Optimal Triage for COVID-19 Patients Under Limited Health Care Resources With a Parsimonious Machine Learning Prediction Model and Threshold Optimization Using Discrete-Event Simulation: Development Study
| JMIR MEDICAL INFORMATICS |
| 2015 | Optimal Waist Circumference Cutoff Value Based on Insulin Resistance and Visceral Obesity in Koreans with Type 2 Diabetes
| DIABETES & METABOLISM JOURNAL |
| 2011 | Optimization of allergen standardization
| YONSEI MEDICAL JOURNAL |
| 2022 | Optimization of FFR prediction algorithm for gray zone by hemodynamic features with synthetic model and biometric data | COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE |
| 2003 | Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer | VIRUS RESEARCH |
| 2013 | Optimized Prognostic Score for Coronary Computed Tomographic Angiography : Results From the CONFIRM Registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2010 | Options for successful renal transplantation in recipients with incompatible living donors: Severance Hospital experience | Clinical Transplants |
| 2023 | Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
| YONSEI MEDICAL JOURNAL |
| 2010 | Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia | OSTEOPOROSIS INTERNATIONAL |
| 2023 | Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
| HAEMATOLOGICA |
| 2023 | Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis | JOURNAL OF CLINICAL PERIODONTOLOGY |
| 2003 | Oral Tegafur-uracil Plus Folinic Acid versus Intravenous 5-fluorouracil Plus Folinic Acid as Adjuvant Chemotherapy of Colon Cancer
| YONSEI MEDICAL JOURNAL |
| 2022 | ORCHARD platform study: Osimertinib plus datopotamab deruxtecan (Dato-DXd) cohort in patients (pts) with advanced NSCLC (aNSCLC) who have progressed on first-line (1L) osimertinib | ANNALS OF ONCOLOGY |
| 2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
| 2023 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON
| CANCER DISCOVERY |
| 2020 | Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study
| JOURNAL OF CLINICAL ONCOLOGY |
| 2020 | Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
| CANCER RESEARCH AND TREATMENT |
| 2018 | Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
| 2017 | Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
| NEW ENGLAND JOURNAL OF MEDICINE |
| 2022 | Osimertinib Plus Durvalumab in Patients With EGFR-Mutated, Advanced NSCLC: A Phase 1b, Open-Label, Multicenter Trial | JOURNAL OF THORACIC ONCOLOGY |
